← Back to Search

Sleep extension for Prediabetes

N/A
Waitlist Available
Led By Susan K Malone, PhD
Research Sponsored by New York University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline and week 12
Awards & highlights
No Placebo-Only Group

Summary

This trial will test whether extending sleep can help regulate blood sugar in adults with pre-diabetes. 150 adults will be randomly assigned to either a sleep extension or habitual sleep group. Data will be collected before and after the 8-week intervention.

Eligible Conditions
  • Prediabetes

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline and week 12
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline and week 12 for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Change in % time glucose is ≥ 140mg/dL

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Sleep extensionExperimental Treatment1 Intervention
Participants in the sleep extension group will keep daily sleep diaries. Sleep diaries will be reviewed with the participant and an instructor trained in Cognitive Behavioral Therapy for Insomnia (CBTI) on a weekly basis. These weekly sessions will take place by telephone or videoconferencing.
Group II: Habitual sleepActive Control1 Intervention
Participants in the habitual sleep group will be instructed to keep their habitual bedtimes and wake times. Participants will keep daily sleep diaries that will we reviewed by a study team member each week. These weekly sessions will take place by telephone or videoconferencing.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Sleep extension
2019
N/A
~220

Find a Location

Who is running the clinical trial?

New York UniversityLead Sponsor
240 Previous Clinical Trials
315,440 Total Patients Enrolled
Susan K Malone, PhDPrincipal InvestigatorNew York University
~29 spots leftby Nov 2025